NCT05072535View on ClinicalTrials.gov

A Study to Evaluate Relative Bioavailability and Food-Effect of HA121-28 Tablet B in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

October 8, 2021

Primary Completion Date

December 19, 2021

Study Completion Date

March 3, 2022

Conditions
Healthy Subjects
Interventions
DRUG

HA121-28 tablet B

HA121-28 tablet B 200 mg

DRUG

HA121-28 tablet A

HA121-28 tablet A 200 mg

Trial Locations (1)

610041

West China Hospital，Sichuan University, Chengdu

All Listed Sponsors
lead

CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

INDUSTRY

NCT05072535 - A Study to Evaluate Relative Bioavailability and Food-Effect of HA121-28 Tablet B in Healthy Subjects | Biotech Hunter | Biotech Hunter